Recruiting

Observational Study

Sponsor:

UCLA

Code:

NCT01336855

Conditions

HIV

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

Conditions

HIV

Study ID

NCT01336855

Start date

Jan, 1988

Status verified date

Apr, 2026

Completion date

Jan, 2030

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort
  • HIV-positive subjects naive to antiretroviral therapy
  • HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months
  • Good venous access
  • Able to provide informed consent

Exclusion Criteria:

  • Hemoglobin < 9g/dl
  • Hematocrit < 27%
  • Active treatment for cancer
  • Hospitalization or IV antibiotic use within the last 4 months
  • Immunosuppressive therapy within the last 4 months

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Arms

HIV Positive

HIV-1 positive subjects

HIV negative subjects

HIV-1 seronegative control group

Primary outcome measure

  • Plasma HIV RNA level [ Time Frame: Ongoing ]

Central Contacts and Locations

Central contacts

Rebecca Hoh, M.S., R.D.

415-476-4082Rebecca.Hoh@ucsf.edu

Viva Tai, MS. RD

415-476-4082Viva.Tai@ucsf.edu

Locations

San Francisco General Hospital

Recruiting

San Francisco, California, United States, 94110

More Information

Sponsor

University of California, San Francisco

Last update posted

Apr 13, 2026

Last verified

Apr, 2026

Keywords

  • HIV
  • Observational
  • Pathogenesis
  • Immunology
  • Virology
  • Control
  • Healthy control
  • Men who have sex with men

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-04-13.